AU1165400A - Novel system for regulating transgene expression - Google Patents

Novel system for regulating transgene expression

Info

Publication number
AU1165400A
AU1165400A AU11654/00A AU1165400A AU1165400A AU 1165400 A AU1165400 A AU 1165400A AU 11654/00 A AU11654/00 A AU 11654/00A AU 1165400 A AU1165400 A AU 1165400A AU 1165400 A AU1165400 A AU 1165400A
Authority
AU
Australia
Prior art keywords
nucleic acid
transgene expression
novel system
expression
tta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11654/00A
Inventor
Olga Corti
Jacques Mallet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9814080A external-priority patent/FR2786198B1/en
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of AU1165400A publication Critical patent/AU1165400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Psychology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Mushroom Cultivation (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Video Image Reproduction Devices For Color Tv Systems (AREA)
  • Circuit Arrangement For Electric Light Sources In General (AREA)

Abstract

The invention concerns novel compositions and methods for controlling nucleic acid expression in cells. More particularly, it concerns any nucleic acid characterised in that it comprises: a) a first region comprising a nucleic acid coding for a tetracycline (tTA)-dependent transactivator under the control of a moderate promoter; and b) a second region comprising a nucleic acid of interest under the control of tTA sensitive promoter. The invention is more particularly useful for controlling the expression of nucleic acids in the nerve cells, in vitro as well as in vivo, for example the human tyrosine hydrocyclosis.
AU11654/00A 1998-11-09 1999-11-09 Novel system for regulating transgene expression Abandoned AU1165400A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9814080A FR2786198B1 (en) 1998-11-09 1998-11-09 NEW SYSTEM FOR REGULATING EXPRESSION OF A TRANSGEN
FR9814080 1998-11-09
US12260099P 1999-03-03 1999-03-03
US60122600 1999-03-03
PCT/FR1999/002752 WO2000028062A1 (en) 1998-11-09 1999-11-09 Novel system for regulating transgene expression

Publications (1)

Publication Number Publication Date
AU1165400A true AU1165400A (en) 2000-05-29

Family

ID=26234639

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11654/00A Abandoned AU1165400A (en) 1998-11-09 1999-11-09 Novel system for regulating transgene expression

Country Status (11)

Country Link
EP (1) EP1129204B1 (en)
JP (1) JP4516215B2 (en)
KR (1) KR20020013476A (en)
CN (1) CN1352694A (en)
AT (1) ATE317020T1 (en)
AU (1) AU1165400A (en)
CA (1) CA2351015C (en)
DE (1) DE69929718T2 (en)
HU (1) HUP0104032A3 (en)
IL (1) IL142761A0 (en)
WO (1) WO2000028062A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440741B2 (en) * 1999-03-15 2002-08-27 The Trustees Of Columbia University In The City Of New York Expression vector for consistent cellular expression of the tet on repressor in multiple cell types
EP1386968A4 (en) * 2001-04-09 2004-12-22 Mitsubishi Pharma Corp Gene expression controlling unit and utilization thereof
CN1453361A (en) * 2003-05-30 2003-11-05 中国科学院上海生命科学研究院 Construction method of virus as anticancer targeting adjustable gene
CA2780671A1 (en) * 2009-11-05 2011-05-12 Proyecto De Biomedicina Cima, S.L. Regulated expression system
CN102690338A (en) * 2012-05-25 2012-09-26 中国农业大学 Protein TetR combinable with tetracycline and coding genes and applications of protein TetR combinable with tetracycline
CN110358812B (en) * 2019-06-25 2022-12-27 武汉生物工程学院 Primer and detection method for gene knockout and recombination positive clone detection of lambda-Red recombination system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2140359T1 (en) * 1993-06-14 2000-03-01 Basf Ag PRECISE CONTROL OF GENETIC EXPRESSION IN EUCARIOTIC CELLS THROUGH PROMOTERS RESPONDING TO TETACICLINE.
US5965440A (en) * 1995-12-07 1999-10-12 The General Hospital Corporation Controlled gene product delivery from a regulatable retroviral vector
WO1998037185A2 (en) * 1997-02-20 1998-08-27 The Board Of Regents Of The University Of Texas System Vectors for controlled gene expression

Also Published As

Publication number Publication date
IL142761A0 (en) 2002-03-10
HUP0104032A3 (en) 2003-09-29
KR20020013476A (en) 2002-02-20
CA2351015C (en) 2011-09-27
JP2002529099A (en) 2002-09-10
HUP0104032A2 (en) 2002-02-28
JP4516215B2 (en) 2010-08-04
ATE317020T1 (en) 2006-02-15
CN1352694A (en) 2002-06-05
DE69929718D1 (en) 2006-04-13
EP1129204B1 (en) 2006-02-01
WO2000028062A1 (en) 2000-05-18
EP1129204A1 (en) 2001-09-05
CA2351015A1 (en) 2000-05-18
DE69929718T2 (en) 2006-11-09

Similar Documents

Publication Publication Date Title
AU4833897A (en) Glial mitogenic factors, their preparation and use
SG141233A1 (en) Control of gene expression
AU3246300A (en) Polypeptides having galactose oxidase activity and nucleic acids encoding same
AU2077197A (en) Polypeptides having phytase activity and nucleic acids encoding same
MX9705039A (en) Programmed cell death genes and proteins.
AU3743395A (en) Novel pesticidal proteins and strains
PL331005A1 (en) Regulating dna of hamster's ef-1alpha transcription
EP1803815A3 (en) Strongly homologous promoter from a hamster
AU4815197A (en) Tetraphosphonate bicyclic trisanhydrides
HUP9801202A2 (en) Method for regulating the expression of a gene in a baculovirus using a retinoic acid receptor binding site, and vector therefor
AU5850999A (en) Fungal transcriptional activator useful in methods for producing polypeptides
AU5155996A (en) Control of pod dehiscence
WO1998051663A3 (en) 3-epi compounds of vitamin d3 and uses thereof
AU7489098A (en) Polypeptides having aminopeptidase activity and nucleic acids encoding same
AU7154096A (en) Blue copper oxidase mutants with enhanced activity
AU1165400A (en) Novel system for regulating transgene expression
AU3593195A (en) Gene encoding carboxypeptidase of aspergillus niger
AU1054699A (en) Cold-inducible expression vector
HK1038572A1 (en) Growth differentiation factor promoter and uses therefor
AU2634597A (en) Compounds with growth hormone releasing properties
AU1896500A (en) High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site
WO2004033653A3 (en) Gene regulation with aptamer and modulator complexes for gene therapy
EP0955375A3 (en) Method for producing optically active 4-Halo-3-Hydroxybutyric acid ester
MY133666A (en) Enzymatic process for stereoselective preparation of therapeutic amides
MX9206265A (en) BIOSYNTHETIC PROCEDURE FOR THE PREPARATION OF CHEMICAL COMPOUNDS.